Medicinal Cannabis: New South Wales (Aus.)
Following calls by the Australian Medical Association (AMA) and
the Law Society of New South Wales for people with illnesses such
as cancer and AIDS to be prescribed cannabis for pain relief, the
Government convened a working party to advise the Government on:
- the efficacy and safety of cannabis for medical purposes;
- the extant medical and scientific literature;
- what further research is required;
- if and how cannabis can be effectively administered with the
least harm to patients;
- if and how cannabis, or any cannabinoid substances, should be
supplied for medical use and how diversion for recreational use
or dealing or trafficking could be avoided in these circumstances;
- legal, ethical, pharmacological, physiological, mental, general
health and community implications and issues concerning the use
of cannabis for medical purposes;
- recommendations to the Government's Expert Advisory Group on
Drugs.
- The working party was chaired by Professor Wayne Hall, Executive
Director of the National Drug and Alcohol Research Centre.
It also included medical academics/clinicians, representatives
from:
- the NSW Cancer Council,
- the AIDS Council of NSW,
- the Law Society of NSW,
- the AMA,
- the Royal Australian College of General Practitioners,
- Government agencies including NSW Police and NSW Health.
Report on the Use of Cannabis for Medical Purposes
The working party produced a Report called the Use of Cannabis
for Medical Purposes.
Volume 1 is an Executive Summary of the report. It contains all
the findings and recommendations from the Working Party. The Executive
Summary is recommended for those seeking an overview of the report.
Volume 2 is the main report and is recommended for anyone wanting
more detailed information.
These are available in pdf format.
Volume
1 (152Kb pdf file)
Volume
2 (659Kb pdf file)
Consultation Process
The Report on the Use of Cannabis for Medical Purposes was released
on 1 November 2000 and interested individuals and groups were invited
to make submissions on the issues raised in the report by 2 February
2001.
The July 2001 Report on the Consultation on the Findings and Recommendations
of the Working Party on the Use of Cannabis for Medical Purposes
was tabled in Parliament on 20 September 2001. This is a report
on the submissions that were received.
The Consultation Report and the Appendices are available in pdf
format. To open these files you will need Acrobat Reader.
Consultation Report (105 Kb pdf file)
Appendices (1.1 Mb pdf file)
NSW Parliament
Medical
Cannabis Programs: A Review of Selected Jurisdictions
A briefing paper by Rowena Johns which outlines the health
benefits and detriments of cannabis use; summarises medical cannabis
laws and programs operating in a range of overseas jurisdictions;
and traces the development of a proposal to authorise the medical
use of cannabis in New South Wales. August 2004
|
Europe:
Read more >>
Canada:
Read more >>
USA:
Read more >>
Australia:
Read more >>
2005 IACM 3rd Conference on Cannabinoids in Medicine:
in Leiden, on 9-10 September 2005, The International Association for Cannabis
as Medicine in cooperation with the Office for Medicinal Cannabis of the Dutch Health
Ministry and the University of Leiden would like to invite you to participate
in the 2005 Meeting of the IACM on September 9-10, 2005 at Leiden University, The Netherlands.
Read more>>
|